ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Business

Ono Pharmaceutical readies heavy dose of US acquisitions

Japanese drugmaker could spend over $3bn in next five years

Ono Pharmaceutical CEO Gyo Sagara

OSAKA -- Ono Pharmaceutical plans to spend 400 billion yen to 500 billion yen ($3.55 billion to $4.44 billion) on acquisitions in the U.S. over the next five years, President and CEO Gyo Sagara told The Nikkei on Friday.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more